Lipotoxicity Induces β-cell Small Extracellular Vesicle-Mediated β-cell Dysfunction in Male Mice

Area of Science:

• Endocrinology and Metabolism
• Cell Biology
• Molecular Medicine

Background:

• Chronic excess free fatty acids (lipotoxicity) contribute to metabolic disorders like type 2 diabetes (T2D).
• Lipotoxicity impairs pancreatic beta-cell function, reducing insulin secretion and promoting cell death.
• The role of beta-cell-derived small extracellular vesicles (sEVs) in lipotoxicity-induced failure is not fully understood.

Purpose of the Study:

• To investigate the role of beta-cell-derived sEVs in lipotoxicity-mediated beta-cell failure.
• To characterize the molecular changes in sEVs released from lipotoxic beta-cells.
• To determine if these sEVs contribute to functional impairment in healthy islets.

Main Methods:

• Exposure of beta-cells to palmitate (PAL) to induce lipotoxicity.
• Analysis of proteomic and lipidomic profiles of released sEVs.
• Treatment of healthy mouse and human islets with PAL-exposed EVs.
• RNA sequencing to identify transcriptional changes in treated islets.
• Pharmacological inhibition of TGFβ receptor to assess pathway involvement.

Main Results:

• Lipotoxicity increased sEV release from beta-cells with altered proteomic and lipidomic profiles.
• PAL-exposed EVs induced dysfunction and significant transcriptional changes in healthy islets.
• Upregulation of genes in the TGFβ/Smad3 pathway was observed.
• Inhibition of TGFβ receptor ameliorated PAL EV-induced beta-cell dysfunction.

Conclusions:

• Lipotoxic beta-cell sEVs are characterized and shown to induce beta-cell dysfunction.
• These sEVs activate the TGFβ/Smad3 pathway, contributing to beta-cell failure in T2D.
• Targeting sEV-mediated pathways presents a potential therapeutic strategy for metabolic disorders.